Iskanje po repozitoriju

A+ | A- | | SLO | ENG

Povzetek: Background: The public perception of dermatology has been poorly investigated in Europe. Objective: To determine the general public's perception of dermatologists in Europe. Methods: This multinational, cross-sectional study was conducted within the framework of the EADV population-based survey on the 'Burden of skin diseases in Europe'. Data were collected using a web-based online survey on a representative sample of the general populations aged 18 years or more of 27 European countries. Proportional quota sampling with replacement design was used for each country. Results: A total of 44,689 adult participants responded to the questionnaire, of whom 18,004 visited a dermatologist in the preceding 3 years. The dermatologist was the second most often visited specialist among all medical specialties, with 69.7%, 72.1%, 42.1% and 78.1% of participants in Western Europe (WE), Eastern Europe (EE), Northern Europe (NE) and Southern Europe (SE), respectively, having consulted a dermatologist over the past 24 months. Most participants across all regions agreed that the dermatologist was the first healthcare provider for chronic skin diseases (61.9% in WE, 69.8% in EE, 45.7% in NE and 60.4% in SE) and for skin cancers (65.5% in WE, 67.6% in EE, 42.4% in NE and 63.0% in SE). The five most common reasons for visiting a dermatologist among all participants were: naevi check-up or skin cancer screening (20.2%), chronic skin diseases (16.5%), acute skin diseases (12.4%), cosmetic advice or procedure (10.2%), hyperpigmentation or congenital lesions (9.1%) and hair or nail disorder (7.7%). Most participants (84.6% in WE, 82.5% in EE, 78.3% in NE and 82.8% in SE) were very swatisfied/somewhat satisfied with the service provided. Conclusion: Our study findings underscore the central role of dermatologists in skin health and highlights them as valued and trusted care providers across Europe. Understanding the perceived position of the dermatologist is the first step in improving health policy development and implementation. Notably, access to a dermatologist was lowest in NE, probably reflecting differences in healthcare organizational structures or possibly cultural differences in healthcare seeking behaviour.
Ključne besede: skin health, public perception, dermatology, chronic skin diseases
Objavljeno v DiRROS: 23.07.2026; Ogledov: 147; Prenosov: 118
Celotno besedilo (263,01 KB)
Gradivo ima več datotek! Več...

Povzetek: Objectives: Febrile illness without clear localisation presents a significant diagnostic challenge due to non-specific symptoms and diverse aetiologies. Spiroplasma ixodetis, an emerging tick-associated pathogen previously linked mainly to congenital cataracts, has not been well characterised in adults. We investigated the prevalence and clinical features of S. ixodetis infection in adults with acute febrile illness without localisation. Methods: Shotgun metagenomic sequencing identified S. ixodetis in the initial 209 patient cohort and the sequences were used to developed a novel real-time PCR assay targeting the 23S rRNA gene. Initial cohort screening was followed by testing 128 patients from an additionally selected targeted cohort. Positive results were confirmed by sequencing of 16S and 23S rRNA genes. Results: S. ixodetis DNA was confirmed in 7.2% patients from the initial and in 35.2% patients from the additional cohort (60 in total). All were identified in the period from April to October and 57% reported a recent tick-bite. Clinical presentation was homogenous, characterised by fever, headache, bicytopenia and liver enzyme abnormalities. Outcomes were favourable, with 15% requiring hospitalisation. Conclusion: This study identifies S. ixodetis as a previously unrecognised cause of adult febrile illness without localisation, bridging the gap between previously published data between tick studies and isolated human case reports.
Ključne besede: 23S rRNA PCR, fever, metagenomics, patients, Spiroplasma ixodetis, tick-borne diseases
Objavljeno v DiRROS: 23.07.2026; Ogledov: 222; Prenosov: 122
Celotno besedilo (2,65 MB)
Gradivo ima več datotek! Več...

Povzetek: Introduction Although some migrant origin groups in Europe show elevated risk for cardiovascular diseases (CVDs) and type 2 diabetes (T2D), information is sparse and fragmented. This study examines availability and possibilities for harmonization of health examination survey (HES) data on major determinants of CVD and T2D among migrant origin and ethnic minority groups in EU Member states and EU4Health associated countries (Norway, Iceland, Ukraine, Moldova, Montenegro). Methods We conducted a scoping review, following PRISMA-ScR in PubMed and Web of Science, supplemented by targeted grey literature searches of national health institutes, to identify HESs covering core risk factors for CVD and T2D among migrant origin and ethnic minority groups, older than 18 years and living in EU Member states and selected associated countries. Studies were published between 2014 and 2026. Altogether 2537 peer-reviewed records and 348 grey literature reports were screened. Following full-text screening, 57 peer-reviewed papers were included. Results In total, 24 individual HESs in 10 countries were identified. The majority (n = 38, 67%) of the surveys were conducted in the Netherlands or Sweden. None of the HESs used nationally representative samples, having been conducted regionally. There was notable heterogeneity in how persons with a migration background and ethnic minorities were defined and grouped. Reported risk factors included obesity, hypertension, hypercholesterolemia, and hyperglycemia. Measurement methods of these risk factors varied by the migrant origin group and country where the study was conducted.
Ključne besede: cardiovascular diseases, type 2 diabetes (T2D)
Objavljeno v DiRROS: 12.07.2026; Ogledov: 197; Prenosov: 74
Povezava na datoteko

Povzetek: Introduction: Acrocyanosis is the most common form of angiodystonic vascular acrosyndrome, characterized by functional microcirculatory alterations without structural vessel damage. It is traditionally classified as either primary or secondary, the latter often associated with underlying conditions. Methods: Some observations suggest a frequent association between acrocyanosis and connective tissue diseases (CTDs). To investigate this, we conducted a study on 53 patients diagnosed with acrocyanosis: 45 females and eight males, 15 to 82 years old, with a mean age of 35 years. Secondary acrocyanosis was identified in 24 patients (45.3%). Results: Advanced age (≥ 40 years) was a significant risk factor for secondary acrocyanosis (relative risk = 2.5, 95% confidence interval: 1.4–4.5, p = 0.002). No significant differences were observed between sexes. CTDs were the most common conditions associated with acrocyanosis (32% of the study population and 71% of the secondary forms). Conclusions: Although generally considered benign, acrocyanosis may indicate an underlying systemic disease. Clinical examination remains essential for the diagnosis of acrocyanosis. Our findings reveal a high prevalence of secondary acrocyanosis associated with CTDs. Patients with strong clinical suspicion should be referred to specialized centers for capillaroscopy and antinuclear antibody testing.
Ključne besede: acrocyanosis, capillaroscopy, connective tissue diseases, microcirculation, non-invasive diagnosis
Objavljeno v DiRROS: 15.06.2026; Ogledov: 252; Prenosov: 147
Celotno besedilo (607,26 KB)
Gradivo ima več datotek! Več...

Povzetek: Objectives: To better understand the Lyme borreliosis (LB) burden in Europe, we aimed to estimate the incidence of symptomatic Borrelia burgdorferi sensu lato (Bbsl) infections after adjusting public health LB surveillance data for under-detection of symptomatic Bbsl infections. Methods: Data from seroprevalence studies and estimates of the symptomatic proportion and duration of antibody detection in Bbsl-infected individuals, derived from reviews of the published literature, were used to adjust public health LB surveillance data to estimate the incidence of symptomatic Bbsl infection in nine European countries from 2018 to 2022. Results: The prevalence of anti-Bbsl antibodies ranged from 2.3% in Romania to 9.4% in Germany. Under- detection multipliers varied across surveillance systems; using 10-year duration of antibody detection, multipliers were 2.4-10.5 in countries reporting all LB cases and 54.6-722.2 in countries reporting only Lyme neuroborreliosis cases. The incidence of symptomatic Bbsl infection adjusted for under-detection was highest in Finland, Germany, Norway, Poland, and Switzerland, intermediate in the Czech Republic and Denmark, and lowest in Ireland and Romania. Conclusion: Adjustment of LB surveillance for under-detection found a high incidence of symptomatic Bbsl infection in several European countries. Differences in LB surveillance systems should be considered when comparing surveillance data between countries and when estimating LB disease burden.
Ključne besede: lyme disease, epidemiology, disease burden, surveillance, seroprevalence, tickborne diseases
Objavljeno v DiRROS: 10.06.2026; Ogledov: 235; Prenosov: 241
Celotno besedilo (885,03 KB)
Gradivo ima več datotek! Več...